Playback speed
10 seconds
Novel Anticoagulants (NOACs): The Data in Standard and High-Risk Patients...Which ones When? Are These Now First-line Therapy?
By
Pulmonary Embolism 2016
FEATURING
Rachel Rosovsky
By
Pulmonary Embolism 2016
FEATURING
Rachel Rosovsky
2,000 views
October 17, 2016
Comments 1
Login to view comments.
Click here to Login
Recommended
AUTOPLAY